Answers are grounded in this paper and cite their sources.
This case report describes the use of intracoronary cangrelor during primary PCI in a patient with essential thrombocythemia and recurrent STEMI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ielasi et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: